of Andrew Graham, managing partner, Jackson Square Capital, is with me to talk about the market action as we sort of wrap up this year. How are you feeling about the market right now. >> Well, I I feel like we've gone through another, you know, pullback in the momentum factor.You see that in the tech tape up until, you know, yesterday's solid solid micron report. Um, and there's follow through today. Um, I think it's kind of chopped.I guess what I'll give you a ba hug. How about that. this time of the year. ...

This year has been one to forget for these pharmaceutical giants.Pfizer (PFE +1.20%) and Merck (MRK +0.71%) are two pharmaceutical giants that have lagged broader equities this year. Both have delivered unimpressive financial results recently, and are facing a somewhat uncertain medium-term outlook as they seek ways to navigate upcoming patent cliffs.Both could make significant progress toward that goal in 2026, but which one is the better option for investors heading into the new year? Let's find out. The ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc ...

Coinbase launched a program that helps businesses create their own stablecoins, and, in a separate project, will help Klarna implement stablecoin funding.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.The company’ ...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Skye securities during the class period because the Company allegedly misled investors regarding the viability of its lead drug candidate. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? According to the complaint, during the class peri ...

SAN DIEGO--(BUSINESS WIRE)---- $PRGO #Health--Robbins LLP: Company: Perrigo Company (NYSE: PRGO) provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally. What is the class period? February 27, 2024 - November 4, 2025 What is the Case About? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who acquired Perrigo securities during the class period because the Company allegedly misled investors regarding the value of its infant for ...

Cheng Xin/Getty Images Nike says its business is midway through a turnaround. Key Takeaways Nike shares, which are down 10% today, are stuck below the prices that predated Elliott Hill's days as CEO. Investors initially welcomed the news that Hill would return to Nike. Today's drop indicates that they're looking for more before declaring the turnaround a success. Nike hoped a new CEO could get its stock rising again. So far, the change just hasn't done it. Shares of Nike (NKE) have fallen some 20% ...

KENNETT SQUARE, Pa., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis) today announced that multiple of its affiliated skilled nursing facilities have earned national recognition from U.S. News & World Report and Newsweek for 2026, reinforcing the organization’s continued commitment to quality, compassionate care and operational excellence as validated by independent, third-party assessments. Across the two respected rankings, Genesis-affiliated centers were recognized for performance in ...

TRENDING: The Next Big AI Roadblock Is On Main Street Today's Spotlight IBD's 12 Days of Holiday Deals Celebrate the holidays with big discounts on IBD's premium products every day from Dec. 13-24. Get Market Insights on IBD Live (© Chris Gash) Next Data Center Roadblock For Google, Microsoft, Oracle, Meta Is On Main Street Partner Center Insurance software play Exzeo (XZO), a recent initial public offering, is approaching its first buy point this week, amid the stock market volatility. As a result, Exzeo i ...